Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Sees Significant Growth in Short Interest

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 33,275 shares, a growth of 114.3% from the May 14th total of 15,525 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Towa Pharmaceutical Price Performance

OTCMKTS:TWAPF opened at $25.33 on Friday. The firm has a 50-day moving average of $25.33 and a two-hundred day moving average of $25.33. Towa Pharmaceutical has a 1-year low of $16.83 and a 1-year high of $25.33.

Analysts Set New Price Targets

Separately, Morgan Stanley upgraded Towa Pharmaceutical to an “overweight” rating in a research report on Friday. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.